$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Sustained release eye drop formulations 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-047/22
  • A61K-031/375
  • A61K-031/522
  • A61K-031/4196
  • A61K-031/5575
  • A61K-031/436
  • A61K-045/06
  • A61K-047/14
  • A61K-047/12
  • A61K-031/573
  • A61K-038/13
  • A61K-009/00
출원번호 US-0017547 (2016-02-05)
등록번호 US-9737606 (2017-08-22)
발명자 / 주소
  • Wong, Vernon G.
  • Wood, Louis L.
출원인 / 주소
  • Ramscor, Inc.
대리인 / 주소
    Wiley Rein LLP
인용정보 피인용 횟수 : 0  인용 특허 : 57

초록

This invention provides for biocompatible, biodegradable eye drop pharmaceutical formulations useful for the treatment of ocular indications. In particular, tocopherols and their esters of low water solubility, notably α-tocopheryl acetate, are exceptional vehicles for biocompatible, nonirritating t

대표청구항

1. A method of treating inflammation of the eye comprising the step of: administering to the eye of a subject in need thereof an eye drop formulation comprising (a) 10% to 15% (wt.) dexamethasone or a derivative, analog, or pharmaceutically acceptable salt thereof dispersed or suspended in 85% to 90

이 특허에 인용된 특허 (57)

  1. Clark Abbot F. (Arlington TX) Conrow Raymond E. (Fort Worth TX), Angiostatic steroids and methods and compositions for controlling ocular hypertension.
  2. Wong Vernon G., Biocompatible ocular implants.
  3. Wong Vernon G. (Rockville MD) Kochinke Frank (San Jose CA), Biocompatible ocular implants.
  4. Wong Vernon G. ; Kochinke Frank, Biocompatible ocular implants.
  5. Wong Vernon G. (Rockville MD), Biodegradable ocular implants.
  6. Wong Vernon G. (Rockville MD), Biodegradable ocular implants.
  7. Wong Vernon G. (Sunnyvale CA), Biodegradable ocular implants.
  8. Vernon Wong ; Lin Peng, Composition and method for treating glaucoma.
  9. Copland, John Alton; Young, Steven L., Compositions and methods for the non-invasive treatment of uterine fibroid cells.
  10. Chen,Guohua; Houston,Paul; Bannister,Roy; Kameda,Teresa; Priebe,David; Kleiner,Lothar, Controlled release depot formulations.
  11. Wong Vernon G. ; Hu Mae W. L. ; Berger ; Jr. Donald E., Controlled-release biocompatible ocular drug delivery implant devices and methods.
  12. Brewer, George J., Copper lowering treatment of inflammatory and fibrotic diseases.
  13. Wong Vernon ; Kochinke Frank, Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents.
  14. Brodbeck Kevin J. ; Gaynor-Duarte Ann T. ; Shen Theodore Tao-Ian, Gel composition and methods.
  15. Kevin J. Brodbeck ; Ann T. Gaynor-Duarte ; Theodore Tao-Ian Shen, Gel composition and methods.
  16. Beuvry, Vincent; Bufala, Georges; Derrieu, Guy, Injectable anthelmintic compositions and methods for using same.
  17. Brodbeck Kevin J. ; Shen Theodore T., Injectable depot gel composition and method of preparing the composition.
  18. Berggren Randall G. (Livermore CA) Enscore David J. (Saratoga CA) Marks Susan M. (San Jose CA) Osborne James L. (Mountain View CA) Wong Patrick S.-L. (Palo Alto CA) Roorda Wouter E. (Newark CA), Injectable drug delivery system and method.
  19. Kato Muneyoshi,JPX ; Ohtsuki Tomohiro,JPX ; Egami Fuminobu,JPX ; Tsunoda Kenji,JPX, Liposome eye drops.
  20. Bezwada Rao S. (Whitehouse Station NJ) Arnold Stephen C. (Franklin NJ) Shalaby Shalaby W. (Anderson SC) Williams Bernard L. (Martinsville NJ), Liquid absorbable copolymers for parenteral applications.
  21. Chern, Rey T.; Zingerman, Joel R., Liquid polymeric compositions for controlled release of bioactive substances.
  22. Williams James B. ; Chern Rey T., Long acting injectable formulations containing hydrogenated caster oil.
  23. Benita, Simon; Lambert, Gregory, Method and composition for dry eye treatment.
  24. Stjernschantz Johan,SEX ; Resul Bahram,SEX, Method and means for prevention and treatment of secondary cataract.
  25. Wong, Vernon G., Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  26. Kim Nam J. (Daejeon-Si KRX) Rhee Byung G. (Daejeon-Si KRX) Cho Heung S. (Daejeon-Si KRX), Method for the preparation of sustained release somatotropin and product produced thereby.
  27. Donovan, Stephen, Method for treating endocrine disorders.
  28. Kaswan Renee (Athens GA), Method of increasing tear production by topical administration of cyclosporin.
  29. Wong Vernon G. (Rockville MD) Lee King Y. (Mission KS) Gin Jerry B. (Sunnyvale CA), Method of treatment of macular degeneration.
  30. Kochinke,Frank, Methods and drug delivery systems for the treatment of orofacial diseases.
  31. Wong, Vernon G.; Hu, Mae W. L., Methods for treating inflammation-mediated conditions of the eye.
  32. Coppeta, Jonathan R.; Santini, Jr., John T.; Uhland, Scott A., Micro-reservoir osmotic release systems and microtube array device.
  33. Shell John W. (Hillsborough CA) Gale Robert M. (Mountain View CA), Ocular insert housing steroid in two different therapeutic forms.
  34. Vanderlaan Douglas G. (Jacksonville FL) Brown-Skrobot Susan K. (Hamilton Square NJ) Schultz Clyde L. (Ponte Vedra Beach FL), Ophthalmic lens with anti-toxin agent.
  35. Guo Luke S. S. (Lafayette CA) Redmann Carl T. (Walnut Creek CA) Radhakrishnan Ramachandran (Palo Alto CA), Ophthalmic liposomes.
  36. Klokkers Karin,DEX ; Fischer Wilfried,DEX, Pharmaceutical composition containing cyclosporin A.
  37. Murthy, Yerramilli V. S. N., Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same.
  38. Yamamoto Masaki (Osaka JPX) Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Miyagawa Tsutomu (Saitama JPX), Polymer, production and use thereof.
  39. Yamamoto Masaki (Osaka JPX) Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Miyagawa Tsutomu (Saitama JPX), Polymer, production and use thereof.
  40. Dunn Richard L. ; Tipton Arthur J., Polymeric compositions useful as controlled release implants.
  41. Gallo-Torres Hugo E. (Livingston NJ) Shah Navnit H. (Clifton NJ), Prostaglandin compositions.
  42. Johan Wilhelm Stjernschantz SE; Bahram Resul SE, Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension.
  43. Herschler Robert J. (3080 NW. 8th Ave. Camas WA 98607), Solid pharmaceutical compositions comprising MSM and their production.
  44. Kim, Nam Joong; Ryoo, Je Phil, Somatotropin composition with improved syringeability.
  45. Bowman Lyle M. ; Patel Rajesh A. ; Ottoboni Thomas B., Sustained release emulsions.
  46. Theeuwes Felix (Los Altos CA), System with microporous releasing diffusor.
  47. Chiou George C. Y. (College Station TX), Systemic delivery of polypeptides through the eye.
  48. Orr ; Thomas Samuel Campbell ; Hall ; David Edward ; Mann ; John, Therapeutic compositions of 1,3-bis(2-carboxychromon-5-yloxyl)propan-2-ol and aspirin or indomethacin.
  49. Sohda Takashi,JPX ; Makino Haruhiko,JPX ; Baba Atsuo,JPX ; Yamane Taihei,JPX, Thienodipyridine derivatives, production and use thereof.
  50. Sonne Mette Rydahl,DKX, Tocopherol compositions for delivery of biologically active agents.
  51. Billson Francis Alfred,AUX ; Penfold Philip Leslie,AUX, Treatment of macular degeneration.
  52. Peyman,Gholam A., Treatment of ocular disease.
  53. Goldblum, David, Treatment of ocular disorders.
  54. Ayer, Atul D.; Lam, Andrew; Magruder, Judy A.; Hamel, Lawrence G.; Wong, Patrick S. L., Uniform drug delivery therapy.
  55. Maniar Manoj L., Use of vitamin E tocopheryl derivatives in ophthalmic compositions.
  56. Shukla, Atul J.; Johnson, James R.; Sun, Yichun; Cooper, Robert; Boring, Gregg; Scruggs, Dan, Vehicles for delivery of biologically active substances.
  57. Stillman, Theodore, Vitamin E compositions and methods.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로